NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
NAVCO Pharmaceuticals Inc., a company specializing in nanotechnology for health products, has granted 3.9 million stock options to its officers, directors, and consultants at $0.05 per share, exercisable over ten years. These options, part of the company’s 2018 stock option plan, vest immediately to aid in the growth of NAVCO, which is focused on innovative defenses against pathogens in various markets, including human health and veterinary services.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.
